Precigen, Inc. (PGEN)
NASDAQ: PGEN · IEX Real-Time Price · USD
1.590
-0.070 (-4.22%)
At close: Jul 19, 2024, 4:00 PM
1.580
-0.010 (-0.63%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Precigen Market Cap
Precigen has a market cap or net worth of $401.35 million as of July 22, 2024. Its market cap has increased by 45.47% in one year.
Market Cap
401.35M
Enterprise Value
363.29M
1-Year Change
45.47%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $401.35M, a decrease of -82.70%. That is a compound annual growth rate of -14.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 401.30M | 20.29% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anika Therapeutics | 409.47M |
| Sonida Senior Living | 407.46M |
| Esperion Therapeutics | 407.30M |
| Cerus | 406.76M |
| Alto Neuroscience | 402.99M |
| AxoGen | 398.59M |
| Lyell Immunopharma | 397.70M |
| enGene Holdings | 397.05M |